Figure S1. ETS-1 is important for cisplatin sensitive HNSCC cell proliferation. Figure S2. ETS-1 is also important for UMSCC74B cell migration and invasion. Figure S3. ETS-1 is important for Cal27 cell migration and invasion. Figure S4. MEK/ERK inhibitor, PD0325901, does not re-sensitize cisplatin-resistant UMSCC74B cells to cisplatin treatment. Figure S5. Dasatinib inhibits cisplatin sensitive Cal27 cell migration and invasion. Figure S6. Dasatinib synergizes with cisplatin to induce apoptosis in SCC25CP cells. (DOCX 1215 kb
Figures S1 to S6. Figure S1: The expression of proteins in GC cells and the sequences of ectopic MAC...
Tables S1 to S4. Table S1: IC50 of different GC cell lines. Table S2: IC50 and RI (resistance index)...
Figure S1. Expression of CSC-associated genes up-regulated in AB12 and RN5 cells after cisplatin tre...
Characterization of MDA-MB231 and cisplatin-resistant MDA-MB231CisR. MDA-MB231 and cisplatin-resista...
A, The expression of STAT3 and pSTAT3 protein in five HNSCC cell lines examined by Western blot. B, ...
A, Immunofluorescence showing subcellular location of E-cadherin, N cadherin and beta-catenin after ...
List of protein identified exclusively in A2780-CisR control (untreated) cells. Table S2. List of pr...
Cisplatin induced NF-κB and its physical interaction with PIK3CA promoter in TOV21G and SKOV3 cells....
Figure S1. The effects of expression of Arf1DN and Arf1CA on HNSCC cell proliferation measured by MT...
Activation of WNT-signalling may contribute to survival of UCCs upon long-term cisplatin treatment. ...
Figure S5. Overexpression of PRKCA reverses the chemosensitization effects of GSK-J4 with regards to...
Differences in suppressive effects of mTORC1 and GSK-3 inhibitors on cell proliferation. Relative ce...
Figure S1. Either knockdown of Src by shRNA (A) or inhibition of Src phosphorylation by saracatinib ...
Figure S1. Establishment of shKRT16, shEHF and miR-365-3p stably expressing cancer cell lines in inv...
Figure S3. Knockdown of KDM6A or KDM6B enhances cisplatin-induced apoptosis in OS cells. Cleaved Cas...
Figures S1 to S6. Figure S1: The expression of proteins in GC cells and the sequences of ectopic MAC...
Tables S1 to S4. Table S1: IC50 of different GC cell lines. Table S2: IC50 and RI (resistance index)...
Figure S1. Expression of CSC-associated genes up-regulated in AB12 and RN5 cells after cisplatin tre...
Characterization of MDA-MB231 and cisplatin-resistant MDA-MB231CisR. MDA-MB231 and cisplatin-resista...
A, The expression of STAT3 and pSTAT3 protein in five HNSCC cell lines examined by Western blot. B, ...
A, Immunofluorescence showing subcellular location of E-cadherin, N cadherin and beta-catenin after ...
List of protein identified exclusively in A2780-CisR control (untreated) cells. Table S2. List of pr...
Cisplatin induced NF-κB and its physical interaction with PIK3CA promoter in TOV21G and SKOV3 cells....
Figure S1. The effects of expression of Arf1DN and Arf1CA on HNSCC cell proliferation measured by MT...
Activation of WNT-signalling may contribute to survival of UCCs upon long-term cisplatin treatment. ...
Figure S5. Overexpression of PRKCA reverses the chemosensitization effects of GSK-J4 with regards to...
Differences in suppressive effects of mTORC1 and GSK-3 inhibitors on cell proliferation. Relative ce...
Figure S1. Either knockdown of Src by shRNA (A) or inhibition of Src phosphorylation by saracatinib ...
Figure S1. Establishment of shKRT16, shEHF and miR-365-3p stably expressing cancer cell lines in inv...
Figure S3. Knockdown of KDM6A or KDM6B enhances cisplatin-induced apoptosis in OS cells. Cleaved Cas...
Figures S1 to S6. Figure S1: The expression of proteins in GC cells and the sequences of ectopic MAC...
Tables S1 to S4. Table S1: IC50 of different GC cell lines. Table S2: IC50 and RI (resistance index)...
Figure S1. Expression of CSC-associated genes up-regulated in AB12 and RN5 cells after cisplatin tre...